Responder Profile to Pharmaceutical-Grade Chondroitin Sulfate: An Analysis of the CONCEPT Trial.
Olivier BruyèreNadia DardenneAnne-Françoise DonneauJean-Yves ReginsterPublished in: Advances in therapy (2020)
ClinicalTrials.gov identifier, NCT03200288.